Carlsmed, Inc.(CARL)
$17.37-0.37 (-2.09%)
CARL
Carlsmed, Inc. financials statements
$17.37
At close:-0.37 (-2.09%)
Want to see CARL full AI Analyst Report?
Carlsmed, Inc. (CARL) Ratios
58 Followers
Carlsmed, Inc. Ratios
CARL's free cash flow for Q3 2026 was $-8.96M. For the 2026 fiscal year, CARL's free cash flow was decreased by $-283.00K and operating cash flow was $-8.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 8.87 | 5.60 | 1.58 |
| Quick Ratio | 8.74 | 5.48 | 1.50 |
| Cash Ratio | 6.01 | 4.55 | 0.97 |
| Solvency Ratio | -0.94 | -0.20 | -0.31 |
| Operating Cash Flow Ratio | -2.03 | -2.89 | -2.35 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -56.72 | -9.51 |
| Net Current Asset Value | $ 95.42M | $ -73.10M | $ -48.39M |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.13 | 0.33 | 0.81 |
| Debt-to-Equity Ratio | 0.18 | -0.24 | -0.25 |
| Debt-to-Capital Ratio | 0.15 | -0.32 | -0.33 |
| Long-Term Debt-to-Capital Ratio | 0.13 | -0.28 | -0.19 |
| Financial Leverage Ratio | 1.32 | -0.73 | -0.30 |
| Debt Service Coverage Ratio | -19.53 | -12.88 | -7.31 |
| Interest Coverage Ratio | -21.38 | -18.26 | -29.00 |
| Debt to Market Cap | 0.09 | 0.07 | 0.14 |
| Interest Debt Per Share | 1.32 | 1.12 | 2.71 |
| Net Debt to EBITDA | 2.45 | 1.01 | -0.23 |
| Profitability Margins | |||
| Gross Profit Margin | 75.31% | 73.80% | 71.88% |
| EBIT Margin | -55.84% | -84.43% | -132.51% |
| EBITDA Margin | -55.28% | -83.90% | -131.52% |
| Operating Profit Margin | -60.53% | -88.80% | -134.93% |
| Pretax Profit Margin | -58.67% | -89.30% | -137.16% |
| Net Profit Margin | -58.67% | -89.30% | -137.16% |
| Continuous Operations Profit Margin | -58.67% | -89.30% | -137.16% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 96.93% | 100.56% | 101.65% |
| Return on Assets (ROA) | -22.77% | -46.81% | -134.75% |
| Return on Equity (ROE) | -29.97% | 34.34% | 40.97% |
| Return on Capital Employed (ROCE) | -26.39% | -56.09% | -282.37% |
| Return on Invested Capital (ROIC) | -26.22% | -54.94% | -212.91% |
| Return on Tangible Assets | -22.77% | -46.81% | -134.75% |
| Earnings Yield | -16.87% | -10.10% | -29.32% |
| Efficiency Ratios | |||
| Receivables Turnover | 4.45 | 4.01 | 4.35 |
| Payables Turnover | 2.78 | 2.95 | 2.29 |
| Inventory Turnover | 6.76 | 7.15 | 6.74 |
| Fixed Asset Turnover | 15.25 | 14.27 | 6.14 |
| Asset Turnover | 0.39 | 0.52 | 0.98 |
| Working Capital Turnover Ratio | 0.66 | 1.21 | 0.00 |
| Cash Conversion Cycle | 4.95 | 18.24 | -21.56 |
| Days of Sales Outstanding | 82.10 | 90.91 | 83.85 |
| Days of Inventory Outstanding | 54.00 | 51.03 | 54.16 |
| Days of Payables Outstanding | 131.15 | 123.70 | 159.56 |
| Operating Cycle | 136.10 | 141.94 | 138.01 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | -2.04 | -1.54 | -3.93 |
| Free Cash Flow Per Share | -2.08 | -1.55 | -3.96 |
| Dividend Paid and CapEx Coverage Ratio | -45.14 | -141.48 | -129.48 |
| Capital Expenditure Coverage Ratio | -45.14 | -141.48 | -129.48 |
| Operating Cash Flow Coverage Ratio | -1.66 | -1.48 | -1.54 |
| Operating Cash Flow to Sales Ratio | -0.57 | -0.94 | -1.27 |
| Free Cash Flow Yield | -16.86% | -10.68% | -27.33% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | -5.83 | -9.90 | -3.41 |
| Price-to-Sales (P/S) Ratio | 3.48 | 8.84 | 4.68 |
| Price-to-Book (P/B) Ratio | 1.78 | -3.40 | -1.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.93 | -9.36 | -3.66 |
| Price-to-Operating Cash Flow Ratio | -6.06 | -9.43 | -3.69 |
| Price-to-Earnings Growth (PEG) Ratio | -0.14 | 0.15 | 0.00 |
| Enterprise Value Multiple | -3.84 | -9.53 | -3.79 |
| Enterprise Value | 107.26M | 217.20M | 68.62M |
| EV to EBITDA | -3.84 | -9.53 | -3.79 |
| EV to Sales | 2.12 | 8.00 | 4.98 |
| EV to Free Cash Flow | -3.62 | -8.47 | -3.90 |
| EV to Operating Cash Flow | -3.70 | -8.53 | -3.93 |
| Tangible Book Value Per Share | 6.95 | -4.26 | -10.38 |
| Shareholders’ Equity Per Share | 6.95 | -4.26 | -10.38 |
| Tax and Other Ratios | |||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 3.55 | 1.64 | 3.10 |
| Net Income Per Share | -2.08 | -1.46 | -4.25 |
| Tax Burden | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.05 | 1.06 | 1.04 |
| Research & Development to Revenue | 0.34 | 0.53 | 0.54 |
| SG&A to Revenue | 1.02 | 1.10 | 0.44 |
| Stock-Based Compensation to Revenue | 0.04 | 0.01 | 0.01 |
| Income Quality | 0.98 | 1.05 | 0.92 |
Currency in USD

